Volume 17, Number 6—June 2011
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
|Variable||Odds ratio (95% CI)||p value|
|Male vs. female||0.207 (0.041–1.016)||0.0523|
|CD4 100–350 vs. CD4 <100 per mm3||4.683 (1.268–17.295)||0.0206|
|CD4 >350 vs. CD4 <100 per mm3||2.448 (0.522–11.468)||0.256|
|Other ethnicity vs. Asian ethnicity||0.295 (0.073–1.191)||0.0864|
|Alcohol history, no vs. yes||1.802 (0.582–5.581)||0.3071|
|Risk group, other vs. MSM||0.422 (0.100–1.774)||0.2392|
|Age at ALT elevation||1.017 (0.966–1.070)||0.5257|
|Duration of ALT elevation||1.001 (1.000–1.002)||0.0207|
*HEV, hepatitis E virus; MSM, men who have sex with men; ALT, alanine aminotransferase.
1These authors contributed equally to this article.
2These authors contributed equally to this article.
Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.